COMPANIES COVERED
RocheDownload FREE Report Sample
Download Free sampleBiosimilar can be defined as a type of biological product that is highly similar to an already FDA approved drug, known as reference biological product.
Biosimilar of Remicade Market contains market size and forecasts of Biosimilar of Remicade in Global, including the following market information:
Global Biosimilar of Remicade Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Biosimilar of Remicade market was valued at 307660 million in 2021 and is projected to reach US$ 490500 million by 2028, at a CAGR of 6.9% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Monoclonal Antibodies Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Biosimilar of Remicade include Roche, Amgen, AbbVie, Sanofi-Aventis, Johnson & Johnson, Pfizer, Novo Nordisk, Eli Lilly and Novartis, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Biosimilar of Remicade companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Biosimilar of Remicade Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Biosimilar of Remicade Market Segment Percentages, by Type, 2021 (%)
Monoclonal Antibodies
Interferon
Erythropoietin
Insulin
Vaccines
Other
Global Biosimilar of Remicade Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Biosimilar of Remicade Market Segment Percentages, by Application, 2021 (%)
Tumor
Diabetes
Cardiovascular
Hemophilia
Other
Global Biosimilar of Remicade Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Biosimilar of Remicade Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Biosimilar of Remicade revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Biosimilar of Remicade revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Amgen
AbbVie
Sanofi-Aventis
Johnson & Johnson
Pfizer
Novo Nordisk
Eli Lilly
Novartis
Merck
3sbio
Changchun High Tech
CP Guojian
Biotech
Gelgen
Innovent
Dong Bao
Ganlee
United Laboratories
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
